Epstein-Barr/JJ
virus/NN
binding/VBG
to/TO
CD21/NN
activates/VBZ
the/DT
initial/JJ
viral/JJ
promoter/NN
via/IN
NF-kappaB/NN
induction/NN
./.

Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
,/,
an/DT
oncogenic/JJ
human/JJ
herpesvirus/NN
,/,
binds/VBZ
to/TO
and/CC
infects/VBZ
normal/JJ
human/JJ
B/NN
lymphocytes/NNS
via/IN
CD21/NN
,/,
the/DT
CR2/NN
complement/NN
receptor/NN
./.
=====
Studies/NNS
of/IN
the/DT
mechanisms/NNS
that/WDT
enable/VBP
EBV/NN
to/TO
infect/VB
nonactivated/JJ
,/,
noncycling/JJ
B/NN
cells/NNS
provide/VBP
compelling/JJ
evidence/NN
for/IN
a/DT
sequence/NN
of/IN
events/NNS
in/IN
which/WDT
EBV/NN
binding/VBG
to/TO
CD21/NN
on/IN
purified/VBN
resting/VBG
human/JJ
B/NN
cells/NNS
rapidly/RB
activates/VBZ
the/DT
NF-kappaB/NN
transcription/NN
factor/NN
,/,
which/WDT
,/,
in/IN
turn/NN
,/,
binds/VBZ
to/TO
and/CC
mediates/VBZ
transcriptional/JJ
activation/NN
of/IN
Wp/NN
,/,
the/DT
initial/JJ
viral/JJ
latent/JJ
gene/NN
promoter/NN
./.
=====
Thus/RB
,/,
EBV/NN
binding/VBG
to/TO
its/PRP$
cellular/JJ
receptor/NN
on/IN
resting/VBG
B/NN
cells/NNS
triggers/VBZ
an/DT
NF-kappaB-dependent/JJ
intracellular/JJ
signaling/NN
pathway/NN
which/WDT
is/VBZ
required/VBN
for/IN
infection/NN
./.